Sun.Jul 21, 2024

article thumbnail

FLiRTy Summer: All You Need to Know About the Latest COVID Variants

Drugs.com

SUNDAY, July 21, 2024 -- As yet another batch of variants fuel a COVID surge this summer, one expert offers advice on how to navigate the threat.“We've seen a bit of a seasonal pattern emerge, where we've had an uptick in COVID in the summer and t.

119
119
article thumbnail

Life signs could survive near surfaces of Enceladus and Europa

Science Daily: Pharmacology News

Europa and Enceladus, icy moons of Jupiter and Saturn respectively, have evidence of oceans beneath their crusts. A NASA experiment suggests -- if these oceans support life -- signatures of that life in the form of organic molecules (like amino acids and nucleic acids) could survive just under the surface ice despite the harsh, ionizing radiation on these worlds.

110
110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview

Drug Patent Watch

The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office (USPTO), established in 2012 by the Leahy-Smith America Invents Act (AIA).

Trials 105
article thumbnail

Stand by Your Case? Without Standing, Supreme Court Precedent Means You’ll Have More Bad Times than Good

FDA Law Blog: Biosimilars

By John W.M. Claud — Sometimes it’s difficult to be a plaintiff, putting all your work into just one case. That’s especially true if recent Supreme Court rulings have rendered your matter a quixotic pursuit, doomed to fail for lack of direct causation. That’s what happened last week in District Court in Maryland. Following the precedent on standing that the Supreme Court handed down in June in FDA v.

Nurses 59
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52
article thumbnail

Raising Welfare for Lab Rodents

Codon

Xander Balwit offers concrete proposals for raising the welfare of animals used in biomedical research for our final article in Issue 03. We’ll be on a brief hiatus for the next few weeks as we prepare for the next Issue! If you’d like to write for us, send a pitch to editors@asimov.com. A hairless and obese rat grimaced at me from behind the glass—its taxidermied gaze fixed on something across the room.

Research 121